![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Latest News
September 8, 2022
August 23, 2022
Tweets
.@myelomaMD of @mayoclinic, is leading a clinical trial to explore an additional treatment for patients with #myeloma who are at high risk of recurrence. For more: https://bit.ly/EAA171OPTIMUM #mmsm cc: @mtmdphd @VincentRK
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
57
Active Clinical Trials
1300
Participating Institutions
67
International Sites
15000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
